Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matão Controlling Hypertension (MatCH Study)
NCT03147092Phase 1Unknown
- Sponsor
- Centro Neurológico de Pesquisa e Reabilitação
- Start
- Feb 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Phase 1, open-label, single-arm trial of captopril, hydrochlorothiazide, atenolol, losartan and Clonidine Lauriad in hypertension (HTN), sponsored by Centro Neurológico de Pesquisa e Reabilitação. Primary endpoint: Number of hypertensive subjects with BP controlled during follow-up at 2 years. Status: unknown.
02
Drugs
captoprilhydrochlorothiazideatenolollosartanClonidine Lauriad
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03147092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147092.